The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010
Treatment strategies for patients with complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety. Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019
Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR) Source: Annual Congress 2009 - Tuberculosis control Year: 2009
Comparison of initial drug treatment of incident COPD patients with German treatment guidelines Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014
Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD) Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Clinical, inflammaory and functional analysis before, during and after treatment with Omalizumabe in patients with difficulty control asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Clinical, radiological,évolutive and génétic aspect of pulmonary tuberculosis(PT) in the erderly subject without comorbidities. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018
Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016
Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013
The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients Source: Eur Respir J 2001; 18: 306-315 Year: 2001
Standard therapy for sarcoidosis Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis Year: 2005
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017
A study of the effectiveness of individual components of pulmonary rehabilitation when compared with the combined programme and standard treatment Source: Eur Respir J 2004; 24: Suppl. 48, 209s Year: 2004